CRBP compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

CRBPCorbus Pharmaceuticals Holdings, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

CRBPCorbus Pharmaceuticals Holdings, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CRBP1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.6%▲+1.78%×0.12

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedCRBP realized, solidLLY realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

CRBPCorbus Pharmaceuticals Holdings, Inc.

3.86▼−1.40%· post 3.86

Mkt cap$74.9MRevenue$1MQ2 FY26Revenue$6MFY25

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,416.42

ClosedNov 3 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 3 '26

CRBPCorbus Pharmaceuticals Holdings, Inc.

LLYELI Lilly & Co

3.86▼−1.40%post 3.86

Price

1,407.25▼−0.27%post 1,416.42

$74.9M

Mkt cap

$1.3T

Q2 FY26$1M

Revenue

$24.4BQ3 FY26

FY25$6M

Revenue

$65.2BFY25

CRBP3.86▼−1.40%vsLLY1,407.25▼−0.27%ClosedNov 3 '26